Sign in
4

Changes in Ownership

Caris Life Sciences, Inc. Filed Acc 0001104659-25-061815

President returned 700,509 shares (to the company)

  • President gave up 34,782 shares (to pay taxes)
  • President acquired 75,000 shares (option exercise)
  • President acquired 132,428 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Spetzler David Baxley President 2025-03-03 Returned to the company −700,509 $18.60 $13,029,467 351,240 D: show line 1 in the form
Spetzler David Baxley President 2025-06-18 Grant or award +132,428 483,668 D: show line 2 in the form
Spetzler David Baxley President 2025-06-20 Option exercise +75,000 $2.44 $183,000 558,668 D: show line 3 in the form
Spetzler David Baxley President 2025-06-20 Shares withheld for taxes −34,782 $27.25 $947,810 523,886 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Spetzler David Baxley President 2025-03-03 Grant or award · Stock Option +750,000 750,000 D: show line 5 in the form
Spetzler David Baxley President 2025-06-20 Option exercise · Stock Option −75,000 0 D: show line 6 in the form
Loading xslF345X05/tm2518641-9_4seq1.xml…